International Clinical Trial: Efficacy and Safety of Lemborexant Combined with Escitalopram in the Treatment of Major Depressive Disorder with Insomnia

Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119476) titled 'Efficacy and Safety of Lemborexant Combined with Escitalopram in the Treatment of Major Depressive Disorder with Insomnia' on Feb. 27.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Peking University Sixth Hospital ( Institute of Mental Health )

Condition: Major depressive disorder with insomnia

Intervention: Experimental group:Escitalopram + Lemborexant

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-03-01

Target Sample Size: Experimental group:143;Control group:143;

Countries of Recruitment: China

To know more, visit https://www.chictr.org...